{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:46:14Z","timestamp":1784331974634,"version":"3.55.0"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,13]]},"DOI":"10.7759\/cureus.92220","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:37:10Z","timestamp":1757777830000},"source":"Crossref","is-referenced-by-count":1,"title":["Impact of Allostatic Load on Chronic Hepatitis B and C: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Chukwuemeka E","family":"Ogbu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N","family":"Kalu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Ezechukwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chinazor","family":"Umerah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.12.061","article-title":"Epidemiology of viral hepatitis and hepatocellular carcinoma","volume":"142","author":"El-Serag HB","year":"2012","unstructured":"El-Serag HB. Epidemiology of viral hepatitis and hepatocellular carcinoma. Gastroenterology. 2012, 142:1264-73. 10.1053\/j.gastro.2011.12.061","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2017.03.14","article-title":"Viral hepatitis and hepatocellular carcinoma: etiology and management","volume":"8","author":"Zamor PJ","year":"2017","unstructured":"Zamor PJ, deLemos AS, Russo MW. Viral hepatitis and hepatocellular carcinoma: etiology and management. J Gastrointest Oncol. 2017, 8:229-42. 10.21037\/jgo.2017.03.14","journal-title":"J Gastrointest Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.14740\/gr1405","article-title":"A focused review on recent advances in the diagnosis and treatment of viral hepatitis","volume":"14","author":"Zhang W","year":"2021","unstructured":"Zhang W, Aryan M, Qian S, Cabrera R, Liu X. A focused review on recent advances in the diagnosis and treatment of viral hepatitis. Gastroenterology Res. 2021, 14:139-56. 10.14740\/gr1405","journal-title":"Gastroenterology Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-12-285960-1.50016-2","article-title":"Psychosocial influences on immunity and infectious disease in humans","author":"Cohen S","year":"1994","unstructured":"Cohen S. Psychosocial influences on immunity and infectious disease in humans. Handbook of Human Stress and Immunity. Glaser R, Kiecolt-Glaser JK (ed): Elsevier, Amsterdam, Netherlands; 1994. 301-19. 10.1016\/B978-0-12-285960-1.50016-2"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/pathogens11091039","article-title":"Determinants of virus variation, evolution, and host adaptation","volume":"11","author":"LaTourrette K","year":"2022","unstructured":"LaTourrette K, Garcia-Ruiz H. Determinants of virus variation, evolution, and host adaptation. Pathogens. 2022, 11:10.3390\/pathogens11091039","journal-title":"Pathogens"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2024.114734","article-title":"Impact of psychological stressors on natural killer cell function: a comprehensive analysis based on stressor type, duration, intensity, and species","volume":"288","author":"Katz AR","year":"2025","unstructured":"Katz AR, Huntwork MP, Kolls JK, Hewes JL, Ellsworth CR, Clark RD, Carlson JC. Impact of psychological stressors on natural killer cell function: a comprehensive analysis based on stressor type, duration, intensity, and species. Physiol Behav. 2025, 288:114734. 10.1016\/j.physbeh.2024.114734","journal-title":"Physiol Behav"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0105530","article-title":"Psychological stress exerts effects on pathogenesis of hepatitis B via type-1\/type-2 cytokines shift toward type-2 cytokine response","volume":"9","author":"He Y","year":"2014","unstructured":"He Y, Gao H, Li X, Zhao Y. Psychological stress exerts effects on pathogenesis of hepatitis B via type-1\/type-2 cytokines shift toward type-2 cytokine response. PLoS One. 2014, 9:e105530. 10.1371\/journal.pone.0105530","journal-title":"PLoS One"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2011.06.004","article-title":"Allostasis: a model of predictive regulation","volume":"106","author":"Sterling P","year":"2012","unstructured":"Sterling P. Allostasis: a model of predictive regulation. Physiol Behav. 2012, 106:5-15. 10.1016\/j.physbeh.2011.06.004","journal-title":"Physiol Behav"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.153.18.2093","article-title":"Stress and the individual: mechanisms leading to disease","volume":"153","author":"McEwen BS","year":"1993","unstructured":"McEwen BS, Stellar E. Stress and the individual: mechanisms leading to disease. Arch Intern Med. 1993, 153:2093-101. 10.1001\/archinte.153.18.2093","journal-title":"Arch Intern Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000510696","article-title":"Allostatic load and its impact on health: a systematic review","volume":"90","author":"Guidi J","year":"2021","unstructured":"Guidi J, Lucente M, Sonino N, Fava GA. Allostatic load and its impact on health: a systematic review. Psychother Psychosom. 2021, 90:11-27. 10.1159\/000510696","journal-title":"Psychother Psychosom"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2217\/hep-2020-0028","article-title":"Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes","volume":"8","author":"Block PD","year":"2020","unstructured":"Block PD, Shinn B, Kim JH, Hann HW. Hepatitis B-related hepatocellular carcinoma and stress: untangling the host immune response from clinical outcomes. Hepat Oncol. 2020, 8:HEP35. 10.2217\/hep-2020-0028","journal-title":"Hepat Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12051177","article-title":"Perceived stress in hepatitis C virus infected patients under the DAA-based therapy","volume":"12","author":"Danilescu CM","year":"2022","unstructured":"Danilescu CM, Ionescu M, Sandulescu DL, Pirlog MC, Streba CT, Rogoveanu I. Perceived stress in hepatitis C virus infected patients under the DAA-based therapy. Diagnostics (Basel). 2022, 12:10.3390\/diagnostics12051177","journal-title":"Diagnostics (Basel)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073917","article-title":"Hepatitis B virus-associated hepatocellular carcinoma and chronic stress","volume":"23","author":"Noverati N","year":"2022","unstructured":"Noverati N, Bashir-Hamidu R, Halegoua-DeMarzio D, Hann HW. Hepatitis B virus-associated hepatocellular carcinoma and chronic stress. Int J Mol Sci. 2022, 23:10.3390\/ijms23073917","journal-title":"Int J Mol Sci"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1746.2006.04110.x","article-title":"Does stress exacerbate liver diseases?","volume":"21","author":"Chida Y","year":"2006","unstructured":"Chida Y, Sudo N, Kubo C. Does stress exacerbate liver diseases?. J Gastroenterol Hepatol. 2006, 21:202-8. 10.1111\/j.1440-1746.2006.04110.x","journal-title":"J Gastroenterol Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.036426","article-title":"Effect of central corticotropin releasing factor on hepatic circulation in rats: the role of the CRF2 receptor in the brain","volume":"54","author":"Yoneda M","year":"2005","unstructured":"Yoneda M, Nakamura K, Nakade Y, et al.. Effect of central corticotropin releasing factor on hepatic circulation in rats: the role of the CRF2 receptor in the brain. Gut. 2005, 54:282-8. 10.1136\/gut.2003.036426","journal-title":"Gut"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1172\/jci38650","article-title":"Hepatic energy state is regulated by glucagon receptor signaling in mice","volume":"119","author":"Berglund ED","year":"2009","unstructured":"Berglund ED, Lee-Young RS, Lustig DG, et al.. Hepatic energy state is regulated by glucagon receptor signaling in mice. J Clin Invest. 2009, 119:2412-22. 10.1172\/jci38650","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/cancers6031670","article-title":"Tumor-associated macrophages as major players in the tumor microenvironment","volume":"6","author":"Chanmee T","year":"2014","unstructured":"Chanmee T, Ontong P, Konno K, Itano N. Tumor-associated macrophages as major players in the tumor microenvironment. Cancers (Basel). 2014, 6:1670-90. 10.3390\/cancers6031670","journal-title":"Cancers (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-012-9866-7","article-title":"Does stress-induced release of interleukin-1 cause liver injury?","volume":"32","author":"Tseilikman V","year":"2012","unstructured":"Tseilikman V, Kozochkin D, Synitsky A, et al.. Does stress-induced release of interleukin-1 cause liver injury?. Cell Mol Neurobiol. 2012, 32:1069-78. 10.1007\/s10571-012-9866-7","journal-title":"Cell Mol Neurobiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1097\/00007890-199711270-00004","article-title":"Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia\/reperfusion injury","volume":"64","author":"Shirasugi N","year":"1997","unstructured":"Shirasugi N, Wakabayashi G, Shimazu M, et al.. Up-regulation of oxygen-derived free radicals by interleukin-1 in hepatic ischemia\/reperfusion injury. Transplantation. 1997, 64:1398-403. 10.1097\/00007890-199711270-00004","journal-title":"Transplantation"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M310175200","article-title":"mRNA is an endogenous ligand for Toll-like receptor 3","volume":"279","author":"Karik\u00f3 K","year":"2004","unstructured":"Karik\u00f3 K, Ni H, Capodici J, Lamphier M, Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem. 2004, 279:12542-50. 10.1074\/jbc.M310175200","journal-title":"J Biol Chem"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20072195","article-title":"TLR-dependent cross talk between human Kupffer cells and NK cells","volume":"205","author":"Tu Z","year":"2008","unstructured":"Tu Z, Bozorgzadeh A, Pierce RH, Kurtis J, Crispe IN, Orloff MS. TLR-dependent cross talk between human Kupffer cells and NK cells. J Exp Med. 2008, 205:233-44. 10.1084\/jem.20072195","journal-title":"J Exp Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.1235","article-title":"A literature review for the mechanisms of stress-induced liver injury","volume":"9","author":"Joung JY","year":"2019","unstructured":"Joung JY, Cho JH, Kim YH, Choi SH, Son CG. A literature review for the mechanisms of stress-induced liver injury. Brain Behav. 2019, 9:e01235. 10.1002\/brb3.1235","journal-title":"Brain Behav"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.1999.277.2.G391","article-title":"Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat","volume":"277","author":"Santos J","year":"1999","unstructured":"Santos J, Saunders PR, Hanssen NP, Yang PC, Yates D, Groot JA, Perdue MH. Corticotropin-releasing hormone mimics stress-induced colonic epithelial pathophysiology in the rat. Am J Physiol. 1999, 277:G391-9. 10.1152\/ajpgi.1999.277.2.G391","journal-title":"Am J Physiol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2013-305690","article-title":"Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism","volume":"63","author":"Vanuytsel T","year":"2014","unstructured":"Vanuytsel T, van Wanrooy S, Vanheel H, et al.. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism. Gut. 2014, 63:1293-9. 10.1136\/gutjnl-2013-305690","journal-title":"Gut"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-015-8644-2","article-title":"Pretreatment with lipopolysaccharide attenuates diethylnitrosamine-caused liver injury in mice via TLR4-dependent induction of Kupffer cell M2 polarization","volume":"62","author":"Li X","year":"2015","unstructured":"Li X, Wang Z, Zou Y, et al.. Pretreatment with lipopolysaccharide attenuates diethylnitrosamine-caused liver injury in mice via TLR4-dependent induction of Kupffer cell M2 polarization. Immunol Res. 2015, 62:137-45. 10.1007\/s12026-015-8644-2","journal-title":"Immunol Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/s0925-4439(01)00055-2","article-title":"The role of Kupffer cell alpha(2)-adrenoceptors in norepinephrine-induced TNF-alpha production","volume":"1537","author":"Zhou M","year":"2001","unstructured":"Zhou M, Yang S, Koo DJ, Ornan DA, Chaudry IH, Wang P. The role of Kupffer cell alpha(2)-adrenoceptors in norepinephrine-induced TNF-alpha production. Biochim Biophys Acta. 2001, 1537:49-57. 10.1016\/s0925-4439(01)00055-2","journal-title":"Biochim Biophys Acta"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/00024382-199606000-00008","article-title":"Met-enkephalin and catecholamine release during feline intestinal ischemia-reperfusion","volume":"5","author":"Aneman A","year":"1996","unstructured":"Aneman A, Medbak S, Watson D, Haglind E. Met-enkephalin and catecholamine release during feline intestinal ischemia-reperfusion. Shock. 1996, 5:434-9. 10.1097\/00024382-199606000-00008","journal-title":"Shock"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.12.003","article-title":"Hepatitis B virus induced hepatocellular carcinoma","volume":"286","author":"Chemin I","year":"2009","unstructured":"Chemin I, Zoulim F. Hepatitis B virus induced hepatocellular carcinoma. Cancer Lett. 2009, 286:52-9. 10.1016\/j.canlet.2008.12.003","journal-title":"Cancer Lett"},{"key":"ref29","article-title":"Hair cortisol and chronic stress exposure in chronic hepatitis B","volume":"9","author":"Hann HW","year":"2019","unstructured":"Hann HW, Meyer J, Park G, Block PD, Juon HS. Hair cortisol and chronic stress exposure in chronic hepatitis B. Clin Investig. 2019, 9:121-7.","journal-title":"Clin Investig"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1176\/appi.psy.45.2.100","article-title":"Psychosocial stress, personality, and the severity of chronic hepatitis C","volume":"45","author":"Nagano J","year":"2004","unstructured":"Nagano J, Nagase S, Sudo N, Kubo C. Psychosocial stress, personality, and the severity of chronic hepatitis C. Psychosomatics. 2004, 45:100-6. 10.1176\/appi.psy.45.2.100","journal-title":"Psychosomatics"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S355314","article-title":"Association between depression or anxiety and the risk of hepatitis B flares: a nationwide population-based cohort study","volume":"15","author":"Tsai MK","year":"2022","unstructured":"Tsai MK, Sytwu HK, Hsieh TY, Chien WC, Lai CH, Chen HC. Association between depression or anxiety and the risk of hepatitis B flares: a nationwide population-based cohort study. J Inflamm Res. 2022, 15:2983-93. 10.2147\/JIR.S355314","journal-title":"J Inflamm Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000062","article-title":"Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study","volume":"7","author":"Shaheen AA","year":"2023","unstructured":"Shaheen AA, Kaplan GG, Sharkey KA, Lethebe BC, Swain MG. Impact of depression and antidepressant use on clinical outcomes of hepatitis B and C: a population-based study. Hepatol Commun. 2023, 7:e0062. 10.1097\/HC9.0000000000000062","journal-title":"Hepatol Commun"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.11.001","article-title":"Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha","volume":"430","author":"Loftis JM","year":"2008","unstructured":"Loftis JM, Huckans M, Ruimy S, Hinrichs DJ, Hauser P. Depressive symptoms in patients with chronic hepatitis C are correlated with elevated plasma levels of interleukin-1beta and tumor necrosis factor-alpha. Neurosci Lett. 2008, 430:264-8. 10.1016\/j.neulet.2007.11.001","journal-title":"Neurosci Lett"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-016-0441-7","article-title":"Functional polymorphism in the interleukin 6 (IL6) gene with respect to depression induced in the course of interferon-\u03b1 and ribavirin treatment in chronic hepatitis patients","volume":"64","author":"Frydecka D","year":"2016","unstructured":"Frydecka D, Paw\u0142owski T, Pawlak D, Ma\u0142yszczak K. Functional polymorphism in the interleukin 6 (IL6) gene with respect to depression induced in the course of interferon-\u03b1 and ribavirin treatment in chronic hepatitis patients. Arch Immunol Ther Exp (Warsz). 2016, 64:169-75. 10.1007\/s00005-016-0441-7","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1497095","article-title":"The role of the interleukin family in liver fibrosis","volume":"16","author":"Zhang Z","year":"2025","unstructured":"Zhang Z, Wang J, Li H, et al.. The role of the interleukin family in liver fibrosis. Front Immunol. 2025, 16:1497095. 10.3389\/fimmu.2025.1497095","journal-title":"Front Immunol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0217263","article-title":"Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis","volume":"14","author":"Kar S","year":"2019","unstructured":"Kar S, Paglialunga S, Jaycox SH, Islam R, Paredes AH. Assay validation and clinical performance of chronic inflammatory and chemokine biomarkers of NASH fibrosis. PLoS One. 2019, 14:e0217263. 10.1371\/journal.pone.0217263","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e3181dc250f","article-title":"Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C","volume":"44","author":"Liu SS","year":"2010","unstructured":"Liu SS, Schneekloth TD, Talwalkar JA, et al.. Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C. J Clin Gastroenterol. 2010, 44:e178-85. 10.1097\/MCG.0b013e3181dc250f","journal-title":"J Clin Gastroenterol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab334","article-title":"Hepatitis C virus direct-acting antiviral treatment adherence patterns and sustained viral response among people who inject drugs treated in opioid agonist therapy programs","volume":"73","author":"Heo M","year":"2021","unstructured":"Heo M, Pericot-Valverde I, Rennert L, et al.. Hepatitis C virus direct-acting antiviral treatment adherence patterns and sustained viral response among people who inject drugs treated in opioid agonist therapy programs. Clin Infect Dis. 2021, 73:2093-100. 10.1093\/cid\/ciab334","journal-title":"Clin Infect Dis"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/5834182","article-title":"HCV integrated care: a randomized trial to increase treatment initiation and SVR with direct acting antivirals","volume":"2017","author":"Groessl EJ","year":"2017","unstructured":"Groessl EJ, Liu L, Sklar M, Ho SB. HCV integrated care: a randomized trial to increase treatment initiation and SVR with direct acting antivirals. Int J Hepatol. 2017, 2017:5834182. 10.1155\/2017\/5834182","journal-title":"Int J Hepatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2010.06.016","article-title":"Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B","volume":"54","author":"Chotiyaputta W","year":"2011","unstructured":"Chotiyaputta W, Peterson C, Ditah FA, Goodwin D, Lok AS. Persistence and adherence to nucleos(t)ide analogue treatment for chronic hepatitis B. J Hepatol. 2011, 54:12-8. 10.1016\/j.jhep.2010.06.016","journal-title":"J Hepatol"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24318","article-title":"Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice","volume":"53","author":"Hongthanakorn C","year":"2011","unstructured":"Hongthanakorn C, Chotiyaputta W, Oberhelman K, Fontana RJ, Marrero JA, Licari T, Lok AS. Virological breakthrough and resistance in patients with chronic hepatitis B receiving nucleos(t)ide analogues in clinical practice. Hepatology. 2011, 53:1854-63. 10.1002\/hep.24318","journal-title":"Hepatology"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.5795","article-title":"Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with Lamivudine","volume":"10","author":"Kamezaki H","year":"2013","unstructured":"Kamezaki H, Kanda T, Arai M, et al.. Adherence to medication is a more important contributor to viral breakthrough in chronic hepatitis B patients treated with entecavir than in those with Lamivudine. Int J Med Sci. 2013, 10:567-74. 10.7150\/ijms.5795","journal-title":"Int J Med Sci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/PSY.0000000000001274","article-title":"The severity of depressive symptoms as an independent predictor of sustained virological response during treatment of hepatitis C with pegylated interferon-\u03b12a and oral ribavirin","volume":"86","author":"Paw\u0142owski T","year":"2024","unstructured":"Paw\u0142owski T, Radkowski M, Perlejewski K, Laskus T, Ma\u0142yszczak K. The severity of depressive symptoms as an independent predictor of sustained virological response during treatment of hepatitis C with pegylated interferon-\u03b12a and oral ribavirin. Psychosom Med. 2024, 86:124-8. 10.1097\/PSY.0000000000001274","journal-title":"Psychosom Med"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3271","article-title":"Depression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis","volume":"12","author":"Zhu HP","year":"2016","unstructured":"Zhu HP, Gu YR, Zhang GL, Su YJ, Wang KE, Zheng YB, Gao ZL. Depression in patients with chronic hepatitis B and cirrhosis is closely associated with the severity of liver cirrhosis. Exp Ther Med. 2016, 12:405-9. 10.3892\/etm.2016.3271","journal-title":"Exp Ther Med"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2005.01.020","article-title":"Psychological status and depression in patients with liver cirrhosis","volume":"37","author":"Bianchi G","year":"2005","unstructured":"Bianchi G, Marchesini G, Nicolino F, et al.. Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis. 2005, 37:593-600. 10.1016\/j.dld.2005.01.020","journal-title":"Dig Liver Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71146-6","article-title":"Social determinants of health inequalities","volume":"365","author":"Marmot M","year":"2005","unstructured":"Marmot M. Social determinants of health inequalities. Lancet. 2005, 365:1099-104. 10.1016\/S0140-6736(05)71146-6","journal-title":"Lancet"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000001843","article-title":"Long-term economic distress and growing educational inequity in life expectancy","volume":"36","author":"Geronimus AT","year":"2025","unstructured":"Geronimus AT, Waidmann TA, Bound J, Pancini V, Yang M. Long-term economic distress and growing educational inequity in life expectancy. Epidemiology. 2025, 36:287-96. 10.1097\/EDE.0000000000001843","journal-title":"Epidemiology"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.gastha.2022.12.001","article-title":"Understanding the changing landscape of health disparities in chronic liver diseases and liver cancer","volume":"2","author":"Herren OM","year":"2023","unstructured":"Herren OM, Gillman AS, Marshall VJ, Das R. Understanding the changing landscape of health disparities in chronic liver diseases and liver cancer. Gastro Hep Adv. 2023, 2:505-20. 10.1016\/j.gastha.2022.12.001","journal-title":"Gastro Hep Adv"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1038\/s43016-022-00577-w","article-title":"Food insecurity has economic root causes","volume":"3","author":"Drewnowski A","year":"2022","unstructured":"Drewnowski A. Food insecurity has economic root causes. Nat Food. 2022, 3:555-6. 10.1038\/s43016-022-00577-w","journal-title":"Nat Food"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1177\/00333549241305256","article-title":"Health equity and viral hepatitis in the United States","author":"Lewis KC","year":"2024","unstructured":"Lewis KC, Heslin KC, McCree DH. Health equity and viral hepatitis in the United States. Public Health Rep. 2024, 10.1177\/00333549241305256","journal-title":"Public Health Rep"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1186\/s40249-024-01225-0","article-title":"Disparities in hepatitis B virus healthcare service access among marginalised poor populations: a mixed-method systematic review","volume":"13","author":"Li C","year":"2024","unstructured":"Li C, Thapa D, Mi Q, Gao Y, Fu X. Disparities in hepatitis B virus healthcare service access among marginalised poor populations: a mixed-method systematic review. Infect Dis Poverty. 2024, 13:58. 10.1186\/s40249-024-01225-0","journal-title":"Infect Dis Poverty"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000001825","article-title":"Gaps and disparities in chronic hepatitis B monitoring and treatment in the United States, 2016-2019","volume":"61","author":"Pham TT","year":"2023","unstructured":"Pham TT, Toy M, Hutton D, et al.. Gaps and disparities in chronic hepatitis B monitoring and treatment in the United States, 2016-2019. Med Care. 2023, 61:247-53. 10.1097\/MLR.0000000000001825","journal-title":"Med Care"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6701a1","article-title":"Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices","volume":"67","author":"Schillie S","year":"2018","unstructured":"Schillie S, Vellozzi C, Reingold A, Harris A, Haber P, Ward JW, Nelson NP. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep. 2018, 67:1-31. 10.15585\/mmwr.rr6701a1","journal-title":"MMWR Recomm Rep"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1002\/nur.20084","article-title":"Allostatic load and health disparities: a theoretical orientation","volume":"28","author":"Carlson ED","year":"2005","unstructured":"Carlson ED, Chamberlain RM. Allostatic load and health disparities: a theoretical orientation. Res Nurs Health. 2005, 28:306-15. 10.1002\/nur.20084","journal-title":"Res Nurs Health"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1177\/1099800405278216","article-title":"Allostatic load: a mechanism of socioeconomic health disparities?","volume":"7","author":"Szanton SL","year":"2005","unstructured":"Szanton SL, Gill JM, Allen JK. Allostatic load: a mechanism of socioeconomic health disparities?. Biol Res Nurs. 2005, 7:7-15. 10.1177\/1099800405278216","journal-title":"Biol Res Nurs"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027717","article-title":"The increasing burden of imported chronic hepatitis B\u2014United States, 1974-2008","volume":"6","author":"Mitchell T","year":"2011","unstructured":"Mitchell T, Armstrong GL, Hu DJ, Wasley A, Painter JA. The increasing burden of imported chronic hepatitis B\u2014United States, 1974-2008. PLoS One. 2011, 6:e27717. 10.1371\/journal.pone.0027717","journal-title":"PLoS One"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1177\/002202217400500402","article-title":"Acculturative stress: the role of ecology, culture and differentiation","volume":"5","author":"Berry JW","year":"1974","unstructured":"Berry JW, Annis RC. Acculturative stress: the role of ecology, culture and differentiation. J Cross Cult Psychol. 1974, 5:382-406. 10.1177\/002202217400500402","journal-title":"J Cross Cult Psychol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.22406","article-title":"Medicaid expansion and restriction policies for hepatitis C treatment","volume":"7","author":"Furukawa NW","year":"2024","unstructured":"Furukawa NW, Ingber SZ, Symum H, et al.. Medicaid expansion and restriction policies for hepatitis C treatment. JAMA Netw Open. 2024, 7:e2422406. 10.1001\/jamanetworkopen.2024.22406","journal-title":"JAMA Netw Open"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s12912-022-00870-w","article-title":"Study protocol: a randomised, controlled trial of a nurse navigator program for the management of hepatitis C virus in patients with severe mental disorder","volume":"21","author":"Quemada-Gonz\u00e1lez C","year":"2022","unstructured":"Quemada-Gonz\u00e1lez C, Morales-Asencio JM, Hurtado MM, Mart\u00ed-Garc\u00eda C. Study protocol: a randomised, controlled trial of a nurse navigator program for the management of hepatitis C virus in patients with severe mental disorder. BMC Nurs. 2022, 21:92. 10.1186\/s12912-022-00870-w","journal-title":"BMC Nurs"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103234","article-title":"Community engagement and chronic viral hepatitis public health interventions: a systematic review, meta-analysis, and complementary crowdsourcing open call","volume":"83","author":"Li Y","year":"2025","unstructured":"Li Y, Kpokiri E, Elasi D, et al.. Community engagement and chronic viral hepatitis public health interventions: a systematic review, meta-analysis, and complementary crowdsourcing open call. EClinicalMedicine. 2025, 83:103234. 10.1016\/j.eclinm.2025.103234","journal-title":"EClinicalMedicine"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1377096","article-title":"The role of culturally appropriate interpersonal communication strategies to reduce hepatitis B and liver cancer disparities","volume":"12","author":"Zovich B","year":"2024","unstructured":"Zovich B, Block SJ, Borondy-Jenkins F, et al.. The role of culturally appropriate interpersonal communication strategies to reduce hepatitis B and liver cancer disparities. Front Public Health. 2024, 12:1377096. 10.3389\/fpubh.2024.1377096","journal-title":"Front Public Health"},{"key":"ref62","unstructured":"Consolidated guidelines on person-centred viral hepatitis strategic information. Using data to support country scale-up of hepatitis prevention, diagnosis and treatment services. (2024). Accessed. May 15, 2025: https:\/\/iris.who.int\/bitstream\/handle\/10665\/376410\/9789240091313-eng.pdf?sequence=1."},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2022.104605","article-title":"Adverse childhood experiences and allostatic load: a systematic review","volume":"136","author":"Finlay S","year":"2022","unstructured":"Finlay S, Roth C, Zimsen T, Bridson TL, Sarnyai Z, McDermott B. Adverse childhood experiences and allostatic load: a systematic review. Neurosci Biobehav Rev. 2022, 136:104605. 10.1016\/j.neubiorev.2022.104605","journal-title":"Neurosci Biobehav Rev"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.physbeh.2011.08.019","article-title":"Adverse childhood experiences, allostasis, allostatic load, and age-related disease","volume":"106","author":"Danese A","year":"2012","unstructured":"Danese A, McEwen BS. Adverse childhood experiences, allostasis, allostatic load, and age-related disease. Physiol Behav. 2012, 106:29-39. 10.1016\/j.physbeh.2011.08.019","journal-title":"Physiol Behav"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaclp.2024.06.006","article-title":"The frequency and impact of adverse childhood experiences on mood, alcohol relapse, and outcomes in liver transplantation: a retrospective cohort study","volume":"65","author":"Fipps DC","year":"2024","unstructured":"Fipps DC, Nguyen T, Meyer R, et al.. The frequency and impact of adverse childhood experiences on mood, alcohol relapse, and outcomes in liver transplantation: a retrospective cohort study. J Acad Consult Liaison Psychiatry. 2024, 65:537-44. 10.1016\/j.jaclp.2024.06.006","journal-title":"J Acad Consult Liaison Psychiatry"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13369-5","article-title":"Adverse childhood experiences and comorbidity in a cohort of people who have injected drugs","volume":"22","author":"Sosnowski DW","year":"2022","unstructured":"Sosnowski DW, Feder KA, Astemborski J, et al.. Adverse childhood experiences and comorbidity in a cohort of people who have injected drugs. BMC Public Health. 2022, 22:986. 10.1186\/s12889-022-13369-5","journal-title":"BMC Public Health"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1177\/11782218231193914","article-title":"The associations of adverse childhood experiences (ACEs) with substance use in young adults: a systematic review","volume":"17","author":"Sebalo I","year":"2023","unstructured":"Sebalo I, K\u00f6nigov\u00e1 MP, Sebalo V\u0148ukov\u00e1 M, Anders M, Pt\u00e1\u010dek R. The associations of adverse childhood experiences (ACEs) with substance use in young adults: a systematic review. Subst Abuse. 2023, 17:10.1177\/11782218231193914","journal-title":"Subst Abuse"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2015.02.022","article-title":"Integrated care increases treatment and improves outcomes of patients with chronic hepatitis C virus infection and psychiatric illness or substance abuse","volume":"13","author":"Ho SB","year":"2015","unstructured":"Ho SB, Br\u00e4u N, Cheung R, et al.. Integrated care increases treatment and improves outcomes of patients with chronic hepatitis C virus infection and psychiatric illness or substance abuse. Clin Gastroenterol Hepatol. 2015, 13:2005-14.e1-3. 10.1016\/j.cgh.2015.02.022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiad227","article-title":"Estimates of hepatitis C seroprevalence and viremia in state prison populations in the United States","volume":"228","author":"Spaulding AC","year":"2023","unstructured":"Spaulding AC, Kennedy SS, Osei J, et al.. Estimates of hepatitis C seroprevalence and viremia in state prison populations in the United States. J Infect Dis. 2023, 228:S160-7. 10.1093\/infdis\/jiad227","journal-title":"J Infect Dis"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2009.04.001","article-title":"Heterogeneity in hepatitis B virus (HBV) seroprevalence estimates from U.S. adult incarcerated populations","volume":"19","author":"Harzke AJ","year":"2009","unstructured":"Harzke AJ, Goodman KJ, Mullen PD, Baillargeon J. Heterogeneity in hepatitis B virus (HBV) seroprevalence estimates from U.S. adult incarcerated populations. Ann Epidemiol. 2009, 19:647-50. 10.1016\/j.annepidem.2009.04.001","journal-title":"Ann Epidemiol"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1159\/000534340","article-title":"Allostatic load and allostatic overload: preventive and clinical implications","volume":"92","author":"Pfaltz MC","year":"2023","unstructured":"Pfaltz MC, Schnyder U. Allostatic load and allostatic overload: preventive and clinical implications. Psychother Psychosom. 2023, 92:279-82. 10.1159\/000534340","journal-title":"Psychother Psychosom"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16074","article-title":"Hepatitis C treatment outcome among people in prison: the SToP-C study","volume":"44","author":"Ryan H","year":"2024","unstructured":"Ryan H, Dore GJ, Grebely J, et al.. Hepatitis C treatment outcome among people in prison: the SToP-C study. Liver Int. 2024, 44:2996-3007. 10.1111\/liv.16074","journal-title":"Liver Int"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0617","article-title":"Prevention of hepatitis C by screening and treatment in U.S. prisons","volume":"164","author":"He T","year":"2016","unstructured":"He T, Li K, Roberts MS, Spaulding AC, Ayer T, Grefenstette JJ, Chhatwal J. Prevention of hepatitis C by screening and treatment in U.S. prisons. Ann Intern Med. 2016, 164:84-92. 10.7326\/M15-0617","journal-title":"Ann Intern Med"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2009.10.002","article-title":"Allostatic load biomarkers of chronic stress and impact on health and cognition","volume":"35","author":"Juster RP","year":"2010","unstructured":"Juster RP, McEwen BS, Lupien SJ. Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev. 2010, 35:2-16. 10.1016\/j.neubiorev.2009.10.002","journal-title":"Neurosci Biobehav Rev"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.11.037","article-title":"New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection","volume":"156","author":"Coffin CS","year":"2019","unstructured":"Coffin CS, Zhou K, Terrault NA. New and old biomarkers for diagnosis and management of chronic hepatitis B virus infection. Gastroenterology. 2019, 156:355-68. 10.1053\/j.gastro.2018.11.037","journal-title":"Gastroenterology"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20095637","article-title":"Architectural allostatic overloading: exploring a connection between architectural form and allostatic overloading","volume":"20","author":"Valentine C","year":"2023","unstructured":"Valentine C. Architectural allostatic overloading: exploring a connection between architectural form and allostatic overloading. Int J Environ Res Public Health. 2023, 20:10.3390\/ijerph20095637","journal-title":"Int J Environ Res Public Health"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s11524-019-00345-5","article-title":"Allostatic load: importance, markers, and score determination in minority and disparity populations","volume":"96","author":"Rodriquez EJ","year":"2019","unstructured":"Rodriquez EJ, Kim EN, Sumner AE, N\u00e1poles AM, P\u00e9rez-Stable EJ. Allostatic load: importance, markers, and score determination in minority and disparity populations. J Urban Health. 2019, 96:3-11. 10.1007\/s11524-019-00345-5","journal-title":"J Urban Health"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.08.045","article-title":"Depression and anxiety are common among patients with cirrhosis","volume":"20","author":"Hernaez R","year":"2022","unstructured":"Hernaez R, Kramer JR, Khan A, et al.. Depression and anxiety are common among patients with cirrhosis. Clin Gastroenterol Hepatol. 2022, 20:194-203.e1. 10.1016\/j.cgh.2020.08.045","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.4314\/ahs.v14i2.18","article-title":"Liver enzymes and psychological well-being response to aerobic exercise training in patients with chronic hepatitis C","volume":"14","author":"Abd El-Kader SM","year":"2014","unstructured":"Abd El-Kader SM, Al-Jiffri OH, Al-Shreef FM. Liver enzymes and psychological well-being response to aerobic exercise training in patients with chronic hepatitis C. Afr Health Sci. 2014, 14:414-9. 10.4314\/ahs.v14i2.18","journal-title":"Afr Health Sci"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30379-8","article-title":"Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis","volume":"388","author":"Rich JD","year":"2016","unstructured":"Rich JD, Beckwith CG, Macmadu A, et al.. Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis. Lancet. 2016, 388:1103-14. 10.1016\/S0140-6736(16)30379-8","journal-title":"Lancet"},{"key":"ref81","article-title":"Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021-2025)","author":"US Department of Health and Human Services","year":"2020","unstructured":"US Department of Health and Human Services. Viral Hepatitis National Strategic Plan for the United States: A Roadmap to Elimination (2021-2025). US Department of Health and Human Services, Washington, DC; 2020."},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1158\/1940-6207.CAPR-11-0450","article-title":"Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis","volume":"5","author":"Nkontchou G","year":"2012","unstructured":"Nkontchou G, Aout M, Mahmoudi A, et al.. Effect of long-term propranolol treatment on hepatocellular carcinoma incidence in patients with HCV-associated cirrhosis. Cancer Prev Res (Phila). 2012, 5:1007-14. 10.1158\/1940-6207.CAPR-11-0450","journal-title":"Cancer Prev Res (Phila)"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-022-00842-z","article-title":"Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: a systemic review and meta-analysis","volume":"23","author":"Chang H","year":"2023","unstructured":"Chang H, Lee SH. Beta-adrenergic receptor blockers and hepatocellular carcinoma survival: a systemic review and meta-analysis. Clin Exp Med. 2023, 23:853-8. 10.1007\/s10238-022-00842-z","journal-title":"Clin Exp Med"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3892\/or_00001032","article-title":"The \u03b2-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor \u03baB signaling","volume":"24","author":"Liao X","year":"2010","unstructured":"Liao X, Che X, Zhao W, Zhang D, Bi T, Wang G. The \u03b2-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor \u03baB signaling. Oncol Rep. 2010, 24:1669-76. 10.3892\/or_00001032","journal-title":"Oncol Rep"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.3109\/13880209.2014.892513","article-title":"Beta-adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration","volume":"52","author":"I\u015feri OD","year":"2014","unstructured":"I\u015feri OD, Sahin FI, Terzi YK, Yurtcu E, Erdem SR, Sarialioglu F. Beta-adrenoreceptor antagonists reduce cancer cell proliferation, invasion, and migration. Pharm Biol. 2014, 52:1374-81. 10.3109\/13880209.2014.892513","journal-title":"Pharm Biol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/373732-impact-of-allostatic-load-on-chronic-hepatitis-b-and-c-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T15:37:11Z","timestamp":1757777831000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/373732-impact-of-allostatic-load-on-chronic-hepatitis-b-and-c-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":85,"URL":"https:\/\/doi.org\/10.7759\/cureus.92220","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,13]]}}}